AI Takeaway
UHS delivered strong Q1 FY2026 results with revenue rising 9.6% YoY to $4.50B and net income growing 10.1% to $348.7M, driven by solid operational performance across its hospital segments.
Revenue
$4.5B
++9.65% YoY
EPS (Basic)
$5.71
++17.25% YoY
Operating Income
$502.86M
++10.56% YoY
Filed · Analysis updated · Source: SEC EDGAR 10-Q filing
Total revenues increased 9.6% YoY from $4.10B to $4.50B in Q1 FY2026, reflecting continued demand for healthcare services and capacity utilization improvements across UHS facilities.
Source: Source: 10-Q Income Statement Data
Operating income grew 10.6% YoY to $502.9M, with operating margin modestly improving from 11.09% to 11.19%, indicating disciplined cost management relative to revenue growth.
Source: Source: 10-Q Income Statement Data
Diluted EPS surged 17.7% YoY from $4.80 to $5.65, outpacing net income growth of 10.1%, suggesting that share buybacks ($163.8M in Q1 FY2026) meaningfully reduced the share count and amplified per-share earnings.
Source: Source: 10-Q Income Statement & Cash Flow Data
2 more insights available
Upgrade to unlockCurrent liabilities jumped 39.2% YoY to $3.24B while current assets grew only 13.7% to $3.50B, resulting in a current ratio of just 1.08x. This tightening liquidity position could constrain UHS's financial flexibility if operational cash flows deteriorate.
Source: Source: 10-Q Balance Sheet Data
Unlock 4 more detailed risk analysis
Upgrade to unlockReported EPS of $5.62 versus the $5.46 analyst consensus — a +2.9% beat for Q1 FY2026.
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $4.5B | $4.1B | +9.65% |
Operating Income | $502.86M | $454.82M | +10.56% |
Net Income | $348.68M | $316.68M | +10.11% |
EPS (Basic) | $5.71 | $4.87 | +17.25% |
EPS (Diluted) | $5.65 | $4.80 | +17.71% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $15.68B | $14.88B | +5.42% |
Current Assets | $3.5B | $3.08B | +13.72% |
Current Liabilities | $3.24B | $2.33B | +39.22% |
Stockholders' Equity | $7.46B | $6.79B | +10.01% |
Cash & Equivalents | $119.03M | $126.75M | -6.09% |
Long-Term Debt | $4.7B | $4.6B | +2.17% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $401.63M | $360.05M | +11.55% |
Investing Cash Flow | $-197.58M | $-271.3M | +27.17% |
Financing Cash Flow | $-221.89M | $-91.42M | -142.72% |
Share Buybacks | $163.85M | $223.38M | -26.65% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 11.2% | 11.1% | +0.09% |
Net Margin | 7.8% | — | — |
ROE | 4.7% | — | — |
ROA | 2.2% | — | — |
Current Ratio | $1.079 | — | — |
Other companies in Health Care Facilities
UHS delivered strong Q1 FY2026 results with revenue of $4.50B, up 9.6% YoY, and net income of $348.7M, up 10.1% YoY. Diluted EPS of $5.65 grew an impressive 17.7% YoY, partly boosted by share buybacks of $163.8M during the quarter.
UHS's 9.6% revenue increase to $4.50B in Q1 FY2026 was driven by continued demand for healthcare services across its hospital network. Operating income grew even faster at 10.6% to $502.9M, suggesting improved operational efficiency alongside volume growth.
Key risks include a sharp 39.2% YoY surge in current liabilities to $3.24B, which compressed the current ratio to a tight 1.08x, and persistent labor cost pressures common in the hospital industry. Long-term debt also stands at $4.70B, adding financial leverage risk in a higher interest rate environment.
UHS's financial health is generally solid, with total assets of $15.68B, stockholders' equity of $7.46B, and operating cash flow of $401.6M. However, the current ratio of 1.08x and cash balance of only $119.0M signal relatively tight near-term liquidity that investors should monitor.
Yes, UHS repurchased $163.8M worth of shares in Q1 FY2026, down 26.7% from $223.4M in Q1 FY2025. These buybacks helped drive diluted EPS growth of 17.7% YoY, which significantly outpaced net income growth of 10.1%.